Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”
Author
Source
International Journal of Rheumatology
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-06-02
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac” [1], there was an error in reference [24] where it should be replaced with the article titled “A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis” [2].
American Psychological Association (APA)
Walker, Chris. 2019. Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”. International Journal of Rheumatology،Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1168469
Modern Language Association (MLA)
Walker, Chris. Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”. International Journal of Rheumatology No. 2019 (2019), pp.1-1.
https://search.emarefa.net/detail/BIM-1168469
American Medical Association (AMA)
Walker, Chris. Erratum to “Are All Oral COX-2 Selective Inhibitors the Same? A Consideration of Celecoxib, Etoricoxib, and Diclofenac”. International Journal of Rheumatology. 2019. Vol. 2019, no. 2019, pp.1-1.
https://search.emarefa.net/detail/BIM-1168469
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1168469
